BamSEC and AlphaSense Join Forces
Learn More

Lucid Diagnostics Inc.

NASDAQ: LUCD    
Share price (9/12/25): $1.03    
Market cap (9/12/25): $112 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 25 pages 12.0% Convertible Secured Promissory Note Due 2029
12/34/56
EX-4.1
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 55 pages Lucid Diagnostics Inc. Senior Secured Convertible Note
12/34/56
EX-4.1
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.5
from S-3 41 pages Lucid Diagnostics Inc., as Issuer, and [ ], as Trustee Indenture Dated as of [ ] [___], 20[__] Subordinated Debt Securities
12/34/56
EX-4.4
from S-3 40 pages Lucid Diagnostics Inc., as Issuer, and [ ], as Trustee Indenture Dated as of [ ] [___], 20[__] Senior Debt Securities
12/34/56
EX-4.1
from 10-K 4 pages The Company Is Authorized to Issue 100,000,000 Shares of Common Stock, Par Value $.001, and 20,000,000 Shares of Preferred Stock, Par Value $.001. as of December 31, 2021, 34,917,907 Shares of Common Stock Are Outstanding (Inclusive of 1,940,740 Shares Underlying Unvested Restricted Stock Awards Granted Under the Lucid Diagnostics Inc. 2018 Long-Term Incentive Equity Plan as of Such Date), and No Shares of Our Preferred Stock Are Outstanding. Preferred Stock
12/34/56
EX-4.2
from S-1/A 7 pages Senior Unsecured Promissory Note
12/34/56
EX-4.1
from S-1/A 2 pages Please Insert Social Security or Other Identifying Number of Assignee
12/34/56